Nuvem’s Post

Switching to IVDR is not a choice. Your FISH lab MUST transition to an IVDR-certified probe if one is available on the EU market. Leading labs are already on track to convert to IVDR-certified FISH probes, to guarantee safe, reliable and effective probes for the welfare of patients. Don’t miss out - it’s not too late to join our webinar and become an IVDR expert. https://lnkd.in/ecESrRYH

Underfunding, dispensing at a loss, and challenges in Pharmacy First implementation are amongst the key concerns and priorities for pharmacy owners in the coming months according to Community Pharmacy England's recent digital briefing event. Focusing on critical pressures and the future, the event gave pharmacy owners the chance to find out more about CPE's work in key areas and share views on important issues. More than 500 pharmacy owners and their representatives registered for the event but, if you missed it, don't worry, you can view a recording here 👇🏻 https://lnkd.in/eErKmBnS #pharmacyfirst #pharmacypressures #communitypharmacy

In a sector where adherence to regulatory standards and quality control are paramount, EMMA International consulting group plays a crucial role in helping life sciences companies meet regulatory requirements, maintain product quality, and ensure patient safety. Learn more in our latest blog here: https://lnkd.in/g-T_3hyf

📅  Day 4 @ ACHEMA 2024 - and the energy is electric!   ⚕😷 🏭❗Swing by the Franz Ziel booth A38 in Hall 3.0 and explore our aseptic processing solutions, championing patient safety with every step. Worried about contamination risks and compliance challenges? Let's navigate them together with tailored solutions and personalized guidance. Elevate your production standards with us!   #asepticprocessing #compliance #patientsafety #pharmaproduction #gmp

Everyone in the pharmacy benefits space has seen this time and time again..... Generic pricing can vary considerably from PBM to PBM, pharmacy to pharmacy, and even with the same PBM at the same pharmacy on the same day. Congressman Auchincloss does an excellent job articulating this fact and how it causes patient affordability and non-adherence issues. Unfortunately, I don't see much changing anytime soon IMHO. #BenefitsConsultants & #Employers - what if you could provide your employees and their dependents access to ~80% of the most commonly prescribed generics with no out-of-pocket cost..... and save the plan money all for a low fixed PEPM? If you don't want to wait for the government to address the issues with generic pricing, please reach out and see how ReviveHealth can address this today. #GenericPricing #AffordableSolutions #WholePersonCare

Troy Medicare is proof positive to congressman Jake Auchincloss's point that utilizing NADAC as the bases of reimbursement does NOT lead to an increase in premiums or overall benefit costs. We use NADAC as bases of reimbursement and maintain a $0 premium as well as $0 deductibles. #TroyMedicare #TroyAI #Pharmacist #IndependentPharmacy #Healthcare #Advocacy #MedicareAdvantage #HealthcareInnovation #Healthplans #PatientCare #Pharmacy #ValueBasedCare #PersonalizedCare #Medicare

Knowledge is power 💪

MSLs - ever been asked if you went to the 'dark side' upon entering the industry? Explore how MSLs can build trust by reading Bridging the Trust Gap here https://lnkd.in/gtkvEgHG #PharmaInsights #TrustInPharma

Mr. Scott, is not close to answering the true question, only trying to improve the public image of PBMs. Thank you congressman Jake Auchincloss for understanding the “true” PBM model, and how the actually do drive up the cost of medications. Example: why would only NameBrand medications be covered, when an AB rated generic is available, hundreds of dollars cheaper. It is because these PBMs are getting significant rebates from the drug manufacturer to keep the namebrand drug on formulary. Does the PBM share theses rebates with the plan sponsor or the dispensing pharmacy….NO! Pockets just getting deeper!!!

News Alert from 340B Report: HRSA Unveils Web Page with Patient Definition Compliance Resources, Guidance - https://lnkd.in/e7mHTUrZ To get full access to 340B Report news reporting and analysis, visit https://lnkd.in/gJd7qNyg #340B #pharmacy #hospitals